Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation
Article in Pharmaceuticals (August 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A
Article in European Journal of Pharmaceutical Sciences (July 2024)
Histone deacetylase 6 as a novel promising target to treat cardiovascular disease
Article in Cancer Innovation (May 2024)